Yuen Adams Hei Long, Wu Po Man, Li Alex Kai Leung, Mak Philip Chung Yin
Department of Diagnostic Radiology and Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
Oncology Centre, St. Teresa's Hospital, Hong Kong Special Administrative Region, China.
Rep Pract Oncol Radiother. 2022 May 19;27(2):352-359. doi: 10.5603/RPOR.a2022.0022. eCollection 2022.
This technical note aims to verify the hippocampus and adjacent organs at risk (OARs) sparing ability of an improved beam arrangement, namely hybrid split-arc partial-field volumetric modulated arc therapy (VMAT) (Hsapf-VMAT) during whole brain radiation therapy (WBRT).
Computed tomography simulation images of 22 patients with brain metastases were retrieved in this retrospective planning study. The hippocampus was manually delineated according to the criterion of RTOG 0933. Plans delivering 30 Gy in 10 fractions were generated for each patient using split-arc partial-field VMAT (sapf-VMAT) and Hsapf-VMAT. The sapf-VMAT plans consisted of 4 arc fields of 179.9° each with reduced field size. The Hsapf-VMAT consisted of 4 arc fields similar to sapf-VMAT in addition to 2 lateral opposing static fields. Statistical comparisons between treatment plans of both techniques were performed using the paired t-test at 5% level significance.
The results demonstrated that Hsapf-VMAT can achieve superior dose sparing in hippocampus which is comparable to sapf-VMAT (p > 0.05). In both eyes, Hsapf-VMAT had significantly lower D and D compared to sapf-VMAT (p < 0.005). Decrease in D of both lenses using Hsapf-VMAT (p < 0.005) were statistically significant when compared to sapf-VMAT. Hsapf-VMAT demonstrated significant reduction of D and D to the optic nerves (p < 0.05). Whole brain planning target volume (PTV) coverage was not compromised in both techniques.
The present study adopts a hybrid technique, namely Hsapf-VMAT, for hippocampal sparing WBRT. Hsapf-VMAT can achieve promising dose reduction to the hippocampus, both eyes and lenses. Therefore, Hsapf-VMAT can be considered an improved version of sapf-VMAT.
本技术说明旨在验证一种改进的射束排列方式,即混合分割弧部分野容积调强弧形放疗(VMAT)(Hsapf-VMAT)在全脑放疗(WBRT)期间对海马体及相邻危及器官(OARs)的保护能力。
在这项回顾性计划研究中,检索了22例脑转移瘤患者的计算机断层扫描模拟图像。根据RTOG 0933标准手动勾勒出海马体。使用分割弧部分野VMAT(sapf-VMAT)和Hsapf-VMAT为每位患者生成10次分割、总剂量30 Gy的计划。sapf-VMAT计划由4个179.9°的弧形野组成,每个野的射野尺寸减小。Hsapf-VMAT除了2个侧向相对的静态野外,还包括4个与sapf-VMAT类似的弧形野。两种技术的治疗计划之间的统计学比较采用配对t检验,显著性水平为5%。
结果表明,Hsapf-VMAT在海马体中可实现更好的剂量保护,与sapf-VMAT相当(p>0.05)。在双眼,Hsapf-VMAT的D和D均显著低于sapf-VMAT(p<0.005)。与sapf-VMAT相比,使用Hsapf-VMAT时两个晶状体的D降低(p<0.005)具有统计学意义。Hsapf-VMAT显示对视神经的D和D显著降低(p<0.05)。两种技术对全脑计划靶区(PTV)的覆盖均未受影响。
本研究采用一种混合技术,即Hsapf-VMAT,用于保护海马体的WBRT。Hsapf-VMAT可实现对海马体、双眼和晶状体有前景的剂量降低。因此,Hsapf-VMAT可被视为sapf-VMAT的改进版本。